Paul P. Tak

机构：Amsterdam UMC Location University of Amsterdam, Celldex Therapeutics (United States), Center for Rheumatology, University of Amsterdam, Stanford University

发表论文 618 篇 · 总被引 62649 次 · h-index 120

代表论文

• Clinical trial links oncolytic immunoactivation to survival in glioblastoma (2023 · Nature · 被引 278)
• A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome (2022 · JCI Insight · 被引 137)
• Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma (2022 · Molecular Therapy — Oncolytics · 被引 40)
• Synovial gene signatures associated with the development of rheumatoid arthritis in at risk individuals: A prospective study (2022 · Journal of Autoimmunity · 被引 20)
• A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma (2025 · Neuro-Oncology · 被引 10)
• The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study (2024 · RMD Open · 被引 9)